Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer: A Comparison With Prostate-Specific Antigen Across Five Randomized Phase III Clinical Trials

G Heller, R McCormack, T Kheoh, A Molina, MR Smith, R Dreicer, F Saad, Ronald de Wit, DT Aftab, M Hirmand, A Limon, K Fizazi, M Fleisher, JS de Bono, HI Scher

Research output: Contribution to journalArticleAcademicpeer-review

147 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)572-+
JournalJournal of Clinical Oncology
Issue number6
Publication statusPublished - 2018

Cite this